Share

April 09, 2019; 92 (15 Supplement) May 9, 2019

The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007)

Kathryn Nichol, Colin Stott, Nicholas Jones, Royston A. Gray, Michael Bazelot, Benjamin J. Whalley
First published April 16, 2019,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 92 no. 15 Supplement P5.5-007
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 16, 2019.
Copyright & Usage: 
© 2019

Author Disclosures

    1. Kathryn Nichol1,
    2. Colin Stott2,
    3. Nicholas Jones2,
    4. Royston A. Gray2,
    5. Michael Bazelot2 and
    6. Benjamin J. Whalley2
  1. Kathryn Nichol1,
  2. Colin Stott2,
  3. Nicholas Jones2,
  4. Royston A. Gray2,
  5. Michael Bazelot2 and
  6. Benjamin J. Whalley2
  1. 1Greenwich Biosciences, Inc. Carlsbad CA United States
  2. 2GW Research Ltd Cambridge United Kingdom

Article usage

Article usage: April 2019 to March 2021

AbstractFullPdfSource
Apr 201911500Highwire
May 20197100Highwire
Jun 20193400Highwire
Jul 20194500Highwire
Aug 20194400Highwire
Sep 20197000Highwire
Oct 20199200Highwire
Nov 201912700Highwire
Dec 201926200Highwire
Jan 202019500Highwire
Feb 202023600Highwire
Mar 202020000Highwire
Apr 202013500Highwire
May 202012900Highwire
Jun 202010600Highwire
Jul 202013300Highwire
Aug 202012800Highwire
Sep 202025600Highwire
Oct 202017300Highwire
Nov 202018800Highwire
Dec 202018700Highwire
Jan 202120800Highwire
Feb 202140600Highwire
Mar 202125100Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me